Hemoglobin crosfumaril API Manufacturers
compare suppliers & get competitive offers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Hemoglobin crosfumaril API 142261-03-8?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Hemoglobin crosfumaril. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Hemoglobin crosfumaril
- Synonyms:
- DCLHb , Hemoglobin A0 (human alpha2 beta2 tetrameric subunit), alpha-chain 99,99'-diamide with (E)-2-butenoic acid , Hemoglobin crosfumaril
- Cas Number:
- 142261-03-8
- DrugBank number:
- DB13864
- Unique Ingredient Identifier:
- FXP28WJO7L
General Description:
Hemoglobin crosfumaril, identified by CAS number 142261-03-8, is a notable compound with significant therapeutic applications. Hemoglobin in which the alpha-subunit are cross-linked intramolecularly.
Classification:
Hemoglobin crosfumaril belongs to the None, classified under the direct parent group Peptides. This compound is a part of the Organic Compounds, falling under the Organic Acids superclass, and categorized within the Carboxylic Acids and Derivatives class, specifically within the Amino Acids, Peptides, and Analogues subclass.
Categories:
Hemoglobin crosfumaril is categorized under the following therapeutic classes: Amino Acids, Peptides, and Proteins, Benzene Derivatives, Blood and Blood Forming Organs, Blood and Related Products, Blood Proteins, Blood Substitutes, Blood Substitutes and Perfusion Solutions, Blood Substitutes and Plasma Protein Fractions, Globins, Hemeproteins, Hydroxybenzoates, Phenols, Proteins. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
Hemoglobin crosfumaril is a type of Other substances
The pharmaceutical industry encompasses a diverse range of active pharmaceutical ingredients (APIs) that are used in the production of various medications. One category of APIs is known as other substances. This category includes substances that do not fall under the conventional classifications such as antibiotics, analgesics, or antihypertensives.
Other substances in pharmaceutical APIs consist of a broad array of chemical compounds with unique properties and applications. These substances play a crucial role in the formulation and development of specialized medications, catering to specific therapeutic needs. The category encompasses various substances like excipients, solvents, stabilizers, and pH adjusters.
Excipients are inert substances that aid in the manufacturing process and enhance the stability, bioavailability, and patient acceptability of pharmaceutical formulations. Solvents are used to dissolve other ingredients and facilitate their incorporation into the final product. Stabilizers ensure the integrity and shelf life of medications by preventing degradation or chemical changes. pH adjusters help maintain the desired pH level of a formulation, which can influence the drug's efficacy and stability.
Pharmaceutical manufacturers carefully select and incorporate specific other substances into their formulations, adhering to regulatory guidelines and quality standards. These substances undergo rigorous testing and evaluation to ensure their safety, efficacy, and compatibility with the desired pharmaceutical product. By employing other substances in API formulations, pharmaceutical companies can optimize drug delivery, improve patient compliance, and enhance therapeutic outcomes.
In summary, the other substances category of pharmaceutical APIs comprises a diverse range of chemicals, including excipients, solvents, stabilizers, and pH adjusters. These substances contribute to the formulation, stability, and performance of medications, enabling pharmaceutical manufacturers to develop specialized products that meet specific therapeutic requirements.
